Development of a Syrian Hamster anti-PD-L1 monoclonal antibody enables adenoviral oncolytic immunotherapy modelling in an immunocompetent virus replication permissive setting

Autor: Clubb J., Kudling T.V., Quixabeira D., Santos J., Havunen R., Heiniö C., Cervera-Carrascon V., Pakola S., Basnet S., Grönberg-Vähä-Koskela s., Kanerva A., & Hemminki A.
Rok vydání: 2023
Zdroj: Frontiers in Immunology
ISSN: 1664-3224
DOI: 10.3389/fimmu.2023.1060540
Databáze: OpenAIRE